The favourable molecular structure of flavonoids enables them to chemically bind to and prevent assembly of the IAPP fibrils and is now emerging as a possible therapeutic strategy for preventing and delaying progression to T2D [14]. Here, IAPP is linked to type 2 diabetes mellitus.